Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3885529 Target Snapshot

Bile acid receptor/Retinoic acid receptor RXR-alpha · PROTEIN COMPLEX · Mus musculus

9Compounds
2Assays
1Approved Drugs
6.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28700. Use UniProt P28700 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28700 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Bile acid receptor/Retinoic acid receptor RXR-alpha as ChEMBL target CHEMBL3885529, mapped to UniProt P28700. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Bile acid receptor/Retinoic acid receptor RXR-alpha
PROTEIN COMPLEX · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3885529
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28700
Retinoic acid receptor RXR-alpha
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Bile acid receptor/Retinoic acid receptor RXR-alpha is the right protein anchor across sources, using UniProt P28700 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRetinoic acid receptor RXR-alpha
UniProt AccessionP28700
Component TypeProtein
Sequence Length467 aa

Retinoic acid receptor RXR-alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Bile acid receptor/Retinoic acid receptor RXR-alpha, mapped to UniProt P28700. ChEMBL maps the protein component as Retinoic acid receptor RXR-alpha. Sequence length is 467 aa.

Mapped IDP28700
Review nameBile acid receptor/Retinoic acid receptor RXR-alpha
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

EC506.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL434750 6.07 EC50 850.0 Preclinical
CHEMBL1915763 5.6 EC50 2500.0 Preclinical
CHEMBL1915761 5.3 EC50 5000.0 Preclinical
CHEMBL240597 4.78 EC50 16800.0 Approved
Distribution

pChEMBL Value Distribution

1
5.0
1
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

2
Total Assays
4
Tested Compounds
1
Assay Types
Functional — 2 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 4 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine